Wednesday, December 2, 2009

Hemispherx's Ampligen Dealt FDA Blow - TheStreet.com


Hemispherx's Ampligen Dealt FDA Blow
TheStreet.com
Hemipsherx shares plunged 43% to 68 cents in Tuesday's after-hours trading session. The FDA's complete response letter to Hemispherx -- summarized in the ...

and more »

No comments:

Post a Comment